Key Details
Price
$0.28Annual ROE
-62.41%Beta
1.49Events Calendar
Next earnings date:
May 15, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Carmell Therapeutics Corporatio doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
CTCX
globenewswire.com29 July 2024
Carmell Corp (Nasdaq: CTCX) announced the appointment of Kendra Bracken-Ferguson as CEO effective July 30, 2024 with Rajiv Shukla continuing as Chairman.
FAQ
- What is the primary business of Carmell Therapeutics Corporatio?
- What is the ticker symbol for Carmell Therapeutics Corporatio?
- Does Carmell Therapeutics Corporatio pay dividends?
- What sector is Carmell Therapeutics Corporatio in?
- What industry is Carmell Therapeutics Corporatio in?
- What country is Carmell Therapeutics Corporatio based in?
- When did Carmell Therapeutics Corporatio go public?
- Is Carmell Therapeutics Corporatio in the S&P 500?
- Is Carmell Therapeutics Corporatio in the NASDAQ 100?
- Is Carmell Therapeutics Corporatio in the Dow Jones?
- When was Carmell Therapeutics Corporatio's last earnings report?
- When does Carmell Therapeutics Corporatio report earnings?
What is the primary business of Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporation (CTCX) focuses on developing innovative biomaterials for medical applications. Their products aim to enhance healing and tissue regeneration, particularly in surgery and wound care. By leveraging advanced technology, CTCX seeks to improve patient outcomes and reduce recovery times in various healthcare settings.
What is the ticker symbol for Carmell Therapeutics Corporatio?
The ticker symbol for Carmell Therapeutics Corporatio is NASDAQ:CTCX
Does Carmell Therapeutics Corporatio pay dividends?
No, Carmell Therapeutics Corporatio does not pay dividends
What sector is Carmell Therapeutics Corporatio in?
Carmell Therapeutics Corporatio is in the Consumer Defensive sector
What industry is Carmell Therapeutics Corporatio in?
Carmell Therapeutics Corporatio is in the Household & Personal Products industry
What country is Carmell Therapeutics Corporatio based in?
Carmell Therapeutics Corporatio is headquartered in United States
When did Carmell Therapeutics Corporatio go public?
Carmell Therapeutics Corporatio's initial public offering (IPO) was on 23 September 2021
Is Carmell Therapeutics Corporatio in the S&P 500?
No, Carmell Therapeutics Corporatio is not included in the S&P 500 index
Is Carmell Therapeutics Corporatio in the NASDAQ 100?
No, Carmell Therapeutics Corporatio is not included in the NASDAQ 100 index
Is Carmell Therapeutics Corporatio in the Dow Jones?
No, Carmell Therapeutics Corporatio is not included in the Dow Jones index
When was Carmell Therapeutics Corporatio's last earnings report?
Carmell Therapeutics Corporatio's most recent earnings report was on 14 November 2024
When does Carmell Therapeutics Corporatio report earnings?
The next expected earnings date for Carmell Therapeutics Corporatio is 15 May 2025